Open-label, prospective and observational study of efficacy and tolerability with levetiracetam during one year of follow-up;Estudio abierto, prospectivo y observacional de eficacia y tolerabilidad con levetiracetam durante 1 año de seguimiento

Neurologia

Volumn 22, Issue 6, 2007, Pages 348-353

  Villanueva, V ^a   Gomez Caigoya A ^a   Gutierrez Delicado E ^a   Serratosa, José M ^a,b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Antiepileptic drugs; Epilepsy; Levetiracetam

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; SOMNOLENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PIRACETAM; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34547176223     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proceed Nation Acad Sci USA 2004;101:9861-6.
2. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55:236-42.
3. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 2000;41:1276-83.
4. Shorvon SD, Lowenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 2000;41:1179-86.
5. Nicolson A, Lewis SA, Smith DF. A prospective analysis of the outcome of levetiracetam in clinical practice. Neurology 2004;63:568-70.
6. Krakow K, Walker M, Otoul C, Sander JW. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 2001;56:1772-4.
7. Ben-Menachem E, Gilland E. Efficacy and tolerability of levetiracetam during 1 year follow-up in patients with refractory epilepsy. Seizure 2003;12:131-5.
8. Betts T, Yarrow H, Greenhill L, Barrett M. Clinical experience of marketed levetiracetam in an epilepsy clinic-a one year follow up study. Seizure 2003;12:136-40.
9. Mohanraj R, Parker PG, Stephen LJ, Brodie MJ. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005;14:23-7.
10. Ben-Menachem E, Edrich P, Van Vleymen B, Sander JW, Schmidt B. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilep Res 2003;53:57-64.
11. Bazil CW, Rose A, Resor S, Yapicular B, Hirsch LJ. Levetiracetam may be more effective for late-onset partial epilepsy. Arch Neurol 2002;59:1905-8.
12. Krauss GL, Betts T, Abou-Khalil B, Gergey G, Yarrow H, Miller A. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure 2003;12:617-20.
13. Kumar SP, Smith PEM. Levetiracetam as add-on therapy in generalised epilepsies. Seizure 2004;13:468-70.
14. Abou-Khalil B, Lazenby B. Long-term experience with levetiracetam. Epilep Disord 2003;5(Suppl. 1):S33-7.
15. Ferrendelli JA, French J, Leppik I, Morrell MJ, Herbeuval A, Han J, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilep Behav 2003;4:702-9.
16. Alsaadi TM, Koopmans S, Apperson M, Farias S. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure 2004;13:58-60.
17. Alsaadi TM, Thieman C, Zusman E. Levetiracetam monotherapy for adults with localization-related epilepsy. Epilep Behav 2002;3:471-4.
18. Alsaadi TM, Thieman C. Levetiracetam monotherapy for newly diagnosed epilepsy patients. Seizure 2003;12:154-6.
19. Alsaadi TM, Shatzel A, Márquez AV, Jorgensen J, Farias S. Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1 year follow-up study. Seizure 2005;14:139-42.